Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: Preliminary validation in humans

Keyphrases

• Myocardial Fibrosis 100%
• Cardiovascular Magnetic Resonance 100%
• Aortic Stenosis 60%
• Hypertrophic Cardiomyopathy 60%
• Fibrosis 40%
• Volume of Distribution 40%
• Diffuse Fibrosis 40%
• Histology 20%
• Non-invasive Quantification 20%
• Aortic Valve Replacement 20%
• Clinical Validation 20%
• Blood Samples 20%
• Continuous Infusion 20%
• Enhancement Techniques 20%
• Myocardial Disease 20%
• Gadolinium Contrast 20%
• Cardiac Disease 20%
• Heart Rate Correction 20%
• Bolus 20%
• Late Gadolinium Enhancement 20%
• Hematocrit 20%
• Inherent Risk 20%
• Sampling Error 20%
• Blood Volume 20%
• Robust Techniques 20%
• Myocardial Biopsy 20%
• Myectomy 20%
• Myocardial Volume 20%
• Surgical Biopsy 20%
• Magnetic Resonance Scan 20%
• Final Ends 20%
• Kendall's tau Coefficient 20%
• Picrosirius Red 20%
• Non-invasive Method 20%
• Fibrosis Quantification 20%

Medicine and Dentistry

• Cardiac Magnetic Resonance Imaging 100%
• Fibrosis 100%
• Cardiac Fibrosis 100%
• Aortic Stenosis 60%
• Hypertrophic Cardiomyopathy 60%
• Biopsy 60%
• Gadolinium 40%
• Volume of Distribution 40%
• Myocardial Disease 20%
• Aortic Valve Replacement 20%
• Heart Disease 20%
• Tau 20%
• Non Invasive Procedure 20%
• Continuous Infusion 20%
• Hematocrit 20%
• Heart Muscle Biopsy 20%
• Muscle Resection 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Heart Muscle Fibrosis 100%
• Fibrosis 100%
• Aortic Stenosis 60%
• Hypertrophic Cardiomyopathy 60%
• Gadolinium 40%
• Volume of Distribution 40%
• Heart Disease 20%
• Myocardial Disease 20%